State of Wisconsin Investment Board’s Teva Pharmaceuticals TEVA Stock Holding History

State of Wisconsin Investment Board’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.4M	Buy	365,722 +4,100	+1%	+$137K	0.03%	579
2026 Q1	$10.9M	Sell	361,622 -78,300	-18%	-$2.52M	0.02%	620
2025 Q4	$13.7M	Sell	439,922 -101,000	-19%	-$2.49M	0.03%	518
2025 Q3	$10.9M	Sell	540,922 -14,000	-3%	-$246K	0.03%	599
2025 Q2	$9.3M	Buy	554,922 +111,900	+25%	+$1.81M	0.02%	674
2025 Q1	$6.81M	Sell	443,022 -6,700	-1%	-$120K	0.02%	803
2024 Q4	$9.91M	Sell	449,722 -37,100	-8%	-$675K	0.03%	653
2024 Q3	$8.77M	Buy	486,822 +59,400	+14%	+$1.04M	0.02%	722
2024 Q2	$6.95M	Buy	427,422 +57,400	+16%	+$884K	0.02%	787
2024 Q1	$5.22M	Buy	370,022 +40,100	+12%	+$505K	0.01%	934
2023 Q4	$3.44M	Sell	329,922 -31,900	-9%	-$298K	0.01%	1105
2023 Q3	$3.69M	Buy	361,822 +25,300	+8%	+$236K	0.01%	1058
2023 Q2	$2.53M	Sell	336,522 -13,300	-4%	-$108K	0.01%	1229
2023 Q1	$3.1M	Buy	349,822 +5,128	+1%	+$50.7K	0.01%	1165
2022 Q4	$3.14M	Sell	344,694 -56,700	-14%	-$495K	0.01%	1167
2022 Q3	$3.24M	Sell	401,394 -46,100	-10%	-$408K	0.01%	1156
2022 Q2	$3.37M	Buy	447,494 +400	+0.1%	+$3.48K	0.01%	1176
2022 Q1	$4.2M	Buy	447,094 +235,572	+111%	+$1.97M	0.01%	1226
2021 Q4	$1.69M	Sell	211,522 -399,433	-65%	-$3.61M	﹤0.01%	1308
2021 Q3	$5.95M	Buy	610,955 +29,100	+5%	+$272K	0.01%	982
2021 Q2	$5.76M	Sell	581,855 -33,278	-5%	-$352K	0.01%	996
2021 Q1	$7.1M	Sell	615,133 -27,888	-4%	-$320K	0.02%	893
2020 Q4	$6.21M	Sell	643,021 -54,400	-8%	-$521K	0.01%	908
2020 Q3	$6.28M	Sell	697,421 -24,100	-3%	-$255K	0.02%	854
2020 Q2	$8.9M	Sell	721,521 -387,662	-35%	-$4.38M	0.02%	652
2020 Q1	$9.96M	Buy	1,109,183 +358,930	+48%	+$3.68M	0.03%	515
2019 Q4	$7.35M	Buy	750,253 +171,784	+30%	+$1.53M	0.02%	794
2019 Q3	$3.98M	Sell	578,469 -810,955	-58%	-$6.21M	0.01%	873
2019 Q2	$12.8M	Buy	1,389,424 +288,229	+26%	+$3.48M	0.04%	513
2019 Q1	$17.3M	Buy	1,101,195 +103,543	+10%	+$1.83M	0.05%	414
2018 Q4	$15.4M	Buy	997,652 +43,952	+5%	+$901K	0.05%	388
2018 Q3	$20.5M	Buy	953,700 +122,100	+15%	+$2.83M	0.06%	356
2018 Q2	$20.2M	Sell	831,600 -42,406	-5%	-$865K	0.06%	349
2018 Q1	$14.9M	Sell	874,006 -721,694	-45%	-$14.1M	0.04%	448
2017 Q4	$30.2M	Sell	1,595,700 -867,140	-35%	-$13M	0.08%	270
2017 Q3	$43.3M	Buy	2,462,840 +227,830	+10%	+$5.13M	0.13%	177
2017 Q2	$74.2M	Buy	2,235,010 +282,860	+14%	+$8.76M	0.24%	91
2017 Q1	$62.6M	Buy	1,952,150 +15,140	+0.8%	+$517K	0.24%	89
2016 Q4	$70.2M	Buy	1,937,010 +1,251,610	+183%	+$50M	0.3%	69
2016 Q3	$31.5M	Buy	+685,400	New	+$35.8M	0.12%	177
2016 Q2	–	Sell	-645,000	Closed	-$34.5M	–	1339
2016 Q1	$34.5M	Buy	645,000 +215,000	+50%	+$12.6M	0.13%	170
2015 Q4	$28.2M	Buy	430,000 +20,000	+5%	+$1.24M	0.11%	212
2015 Q3	$23.1M	Buy	410,000 +52,000	+15%	+$3.37M	0.09%	261
2015 Q2	$21.2M	Sell	358,000 -430,000	-55%	-$26.5M	0.07%	322
2015 Q1	$49.1M	Buy	788,000 +387,000	+97%	+$22.5M	0.17%	141
2014 Q4	$23.1M	Hold	401,000	–	–	0.08%	302
2014 Q3	$21.6M	Buy	401,000 +107,000	+36%	+$5.67M	0.08%	301
2014 Q2	$15.4M	Sell	294,000 -46,000	-14%	-$2.35M	0.06%	416
2014 Q1	$18M	Buy	340,000 +70,000	+26%	+$3.24M	0.07%	345
2013 Q4	$10.8M	Sell	270,000 -80,000	-23%	-$3.15M	0.04%	518
2013 Q3	$13.2M	Sell	350,000 -628,000	-64%	-$24.5M	0.05%	424
2013 Q2	$38.3M	Buy	+978,000	New	+$38.1M	0.16%	134

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

State of Wisconsin Investment Board's TEVA Position: Q2 2026 in Review

State of Wisconsin Investment Board increased its Teva Pharmaceuticals (TEVA) stake by 1.1% in Q2 2026, buying an estimated $137K and bringing the position to 365,722 shares worth $12.4M. The position accounts for 0.03% of the portfolio, ranked #579.

State of Wisconsin Investment Board first reported a position in TEVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $74.2M in Q2 2017. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

State of Wisconsin Investment Board held 365,722 shares of Teva Pharmaceuticals worth $12.4M as of Q2 2026.
State of Wisconsin Investment Board bought 4,100 Teva Pharmaceuticals shares in Q2 2026, an estimated $137K.
Teva Pharmaceuticals made up 0.03% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #579 holding.
State of Wisconsin Investment Board first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
State of Wisconsin Investment Board's Teva Pharmaceuticals position peaked at $74.2M in Q2 2017.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.